Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey

Lieve Van Hoovels*, Sylvia Broeders, Edward K. L. Chan, Luis Andrade, Wilson de Melo Cruvinel, Jan Damoiseaux, Markku Viander, Manfred Herold, Wim Coucke, Ingmar Heijnen, Dimitrios Bogdanos, Jaime Calvo-Alen, Catharina Eriksson, Ana Kozmar, Liisa Kuhi, Carolien Bonroy, Bernard Lauwerys, Sofie Schouwers, Laurence Lutteri, Martine VercammenMiroslav Mayer, Dina Patel, William Egner, Kari Puolakka, Andrea Tesija-Kuna, Yehuda Shoenfeld, Maria Jose Rego de Sousa, Marcos Lopez Hoyos, Antonella Radice, Xavier Bossuyt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number17
Number of pages12
JournalAutoimmunity Highlights
Volume11
Issue number1
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Antinuclear antibodies
  • ANA patterns
  • Indirect immunofluorescence
  • ICAP
  • CONSENSUS
  • AUTOANTIBODIES
  • ANTI-DFS70
  • PREVALENCE
  • DIAGNOSIS
  • TESTS

Cite this